Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsPayablesPrepaid AssetsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cyclerion Therapeutics (CYCN) Other Non-Current Assets (2019 - 2023)

Cyclerion Therapeutics (CYCN) has disclosed Other Non-Current Assets for 5 consecutive years, with $1.9 million as the latest value for Q2 2023.

  • For Q2 2023, Other Non-Current Assets fell 16.41% year-over-year to $1.9 million; the TTM value through Jun 2023 reached $1.9 million, down 16.41%, while the annual FY2022 figure was $2.0 million, 15.21% down from the prior year.
  • Other Non-Current Assets hit $1.9 million in Q2 2023 for Cyclerion Therapeutics, down from $2.0 million in the prior quarter.
  • Across five years, Other Non-Current Assets topped out at $7.7 million in Q2 2019 and bottomed at $19000.0 in Q1 2019.
  • Average Other Non-Current Assets over 5 years is $2.9 million, with a median of $2.3 million recorded in 2022.
  • On a YoY basis, Other Non-Current Assets climbed as much as 5473.68% in 2020 and fell as far as 81.98% in 2020.
  • Cyclerion Therapeutics' Other Non-Current Assets stood at $5.0 million in 2019, then dropped by 23.12% to $3.8 million in 2020, then plummeted by 37.27% to $2.4 million in 2021, then decreased by 15.21% to $2.0 million in 2022, then fell by 8.92% to $1.9 million in 2023.
  • According to Business Quant data, Other Non-Current Assets over the past three periods came in at $1.9 million, $2.0 million, and $2.0 million for Q2 2023, Q1 2023, and Q4 2022 respectively.